Botulinum Toxin Market to Reach Valuation of USD 13.4 Bn at CAGR of 8.4% by 2032
08 mai 2023 06h42 HE
|
Market.Us
New York, May 08, 2023 (GLOBE NEWSWIRE) -- In terms of revenue, The global Botulinum Toxin Market is estimated to exceed US$ 13.4 billion by 2032 from USD 6.1 billion in 2022, expanding at a CAGR of...
New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain
25 avr. 2023 10h00 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or...
Global Chronic Pain Market Size To worth $140.5 billion By 2030, CAGR of 5.8% | Spherical Insights
21 avr. 2023 08h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , April 21, 2023 (GLOBE NEWSWIRE) -- The Global Chronic Pain Market Size to grow from USD 69.1 billion in 2021 to USD 140.5 billion by 2030, at a Compound Annual Growth Rate...
Intrathecal Pumps Market to Raise at a CAGR of 4.5% During 2022 to 2031 | TMR
28 mars 2023 11h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 28, 2023 (GLOBE NEWSWIRE) -- According to the latest study by Transparency Market Research, the global intrathecal pumps market stood at USD 280.5 Mn in...
SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference
16 mars 2023 08h00 HE
|
SPR Therapeutics, Inc.
CLEVELAND, March 16, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients suffering from acute or...
SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System
03 févr. 2023 15h32 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Feb. 03, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic...
Chronic Pain Market is Estimated to Record a CAGR of 6.9% During the Forecast Period 2023 – 2033 | Future Market Insights, Inc.
31 déc. 2022 05h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Dec. 31, 2022 (GLOBE NEWSWIRE) -- The chronic pain market is anticipated to grow from US$ 73.14 Bn in 2023 to US$ 142.53 Bn by 2033, rising at a CAGR of 6.9% during the forecast period....
IGC Announces Updated Life Sciences Presentation
20 déc. 2022 08h30 HE
|
INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Dec. 20, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”), today announces that a life sciences presentation has been filed with...
Le lieutenant-général (ret) J.O. Michel Maisonneuve dirigera la campagne de financement à l’appui de la recherche et des traitements pour les vétérans vivant avec la douleur chronique
10 nov. 2022 07h00 HE
|
Centre d’excellence sur la douleur chronique pour les vétérans canadiens
HAMILTON, Ontario, 10 nov. 2022 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens (CESLDC) est heureux d’annoncer la nomination du lieutenant-général...
Lieutenant-General (retired) J.O. Michel Maisonneuve to lead fundraising efforts supporting research and treatment for Veterans experiencing chronic pain
10 nov. 2022 07h00 HE
|
Chronic Pain Centre of Excellence for Canadian Veterans
HAMILTON, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans (CPCoE) is excited to announce it has appointed Lieutenant-General (retired) J.O....